Human amniotic fluid derived exosomes affect neuropathic pain after spared nerve injury in mice

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100051218

Enrollment

Unknown

Registered

2021-09-16

Start date

2021-10-10

Completion date

Unknown

Last updated

2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neuropathic pain

Interventions

group 1:No

group 2:No

Eligibility

Sex/Gender

Female

Age

28 Years to 35 Years

Inclusion criteria

Inclusion criteria: Amniotic fluid samples in the second trimester of pregnancy are taken from amniotic fluid samples obtained from pregnant women aged 28-35 who need amniocentesis. Only amniotic fluid samples with normal amniocentesis results can be used in further experiments. Amniotic fluid samples in the third trimester of pregnancy are taken from healthy pregnant women aged 28-35 who need cesarean section, and the fetus is born without malformation, neonatal asphyxia and other neonatal diseases, and the amniotic fluid is not polluted.

Exclusion criteria

Exclusion criteria: No.

Design outcomes

Primary

Measure	Time frame
Mechanical pain and thermal pain;	—

Countries

China

Contacts

Public ContactYang Yong

Xiangya Hospital of Central South University

yangwulf@163.com+86 13873151125

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026